Adaptimmune Therapeutics PLC (ADAP)
Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.
Address
60 JUBILEE AVENUE
ABINGDON, OXFORDSHIRE, X0 OX14 4RX
Founded
2008
Number of Employees
449
Website
http://www.adaptimmune.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)